NCT02738996

Brief Summary

Type-2 diabetes, a common non-infectious disease, is the result of impaired insulin function and insulin production in the body. In type-2 diabetic patients, postprandial glucose control, lipid control and reduction of insulin resistance are crucial to deter the development of diabetes related complications (e.g. retinopathy, nephropathy, neuropathy and cardiovascular diseases), pancreatic β cells failure, morbidity and mortality. Currently, diet, exercise and standard oral medicines are used to treat type-2 diabetes. However, providing the most effective treatment to control postprandial glucose and lipid; and to preserve the pancreatic β cells is challenging because poor metabolic profiles are still detected in type-2 diabetic patients. Therefore, understanding the factors influencing the poor metabolic profiles and adjunct therapy to manage type-2 diabetes are really important to tackle this disease. In modern society, people are spending most of their waking time in sedentary behaviour, which is primarily prolonged sitting. Prolonged sedentary time is associated with increased postprandial glucose, lipid and insulin resistance. In contrast, frequent interruption of prolonged sitting with short light activity break reduces postprandial glucose, triglyceride cholesterol and insulin resistance. However, how frequently patients should interrupt sitting, potential longer-term effect of short activity break on reduction of postprandial glucose, triglyceride cholesterol and insulin resistance, and the knowledge, beliefs and experiences on the use of technology to decrease sedentary behaviour and improve glycaemic control are not investigated in type-2 diabetic patients. Therefore, it would be relevant to investigate this to prove the therapeutic role of frequent short activity break in sedentary time in the management of type-2 diabetes. Primary Research Objective:

  1. 1.To investigate the dose-response effect of frequency/number of light intensity walking breaks of sitting on postprandial glucose, insulin, C-peptide and triglyceride cholesterol level.
  2. 2.To investigate the potential longer-term effect of light intensity walking breaks of sitting on glucose control using 24-h glucose data.
  3. 3.To obtain data to inform the development of a future feasibility trial investigating the feasibility, compliance, adherence and longer-term effect of different frequencies of light intensity walking breaks in sitting time on glycaemic excursions in free-living.
  4. 4.To explore the knowledge, beliefs and experiences of those with Type 2 diabetes on the use of technology to decrease sedentary behaviour and improve glycaemic control, that could be used in the feasibility trial

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable diabetes

Timeline
Completed

Started May 2016

Shorter than P25 for not_applicable diabetes

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 14, 2016

Completed
17 days until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

April 14, 2016

Status Verified

March 1, 2016

Enrollment Period

8 months

First QC Date

March 30, 2016

Last Update Submit

April 11, 2016

Conditions

Keywords

DiabetesSedentary Lifestyle

Outcome Measures

Primary Outcomes (1)

  • Postprandial glucose excursions measured with Area under curve

    Dose-response relationship between frequencies of short light activity breaks in sedentary time and postprandial glucose excursions

    8 hours

Secondary Outcomes (3)

  • 24 hours glucose profile measured with continuous glucose monitor LifeStyle Libre

    24 hours

  • Insulin, C-peptide and triglyceride cholesterol plasma level during the intervention measured with Area under curve

    8 hours

  • Qualitative exploration of the knowledge, beliefs and experiences of those with type 2 diabetes on the use of technology to decrease sedentary behaviour and improve glycaemic control

    1 hour

Study Arms (6)

60-30 min

EXPERIMENTAL

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 60 min and 30 min

Behavioral: Sedentary time breaks either every 60 minutesBehavioral: Sedentary time breaks either every 30 minutes

30-15 min

EXPERIMENTAL

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min and 15 min

Behavioral: Sedentary time breaks either every 30 minutesBehavioral: Sedentary time breaks every 15 minutes

15-60 min

EXPERIMENTAL

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 15 min and 60 min

Behavioral: Sedentary time breaks either every 60 minutesBehavioral: Sedentary time breaks every 15 minutes

60-15

EXPERIMENTAL

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 60 min and 15 min

Behavioral: Sedentary time breaks either every 60 minutesBehavioral: Sedentary time breaks every 15 minutes

30-60 min

EXPERIMENTAL

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min and 60 min

Behavioral: Sedentary time breaks either every 60 minutesBehavioral: Sedentary time breaks either every 30 minutes

15-30 min

EXPERIMENTAL

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 15 min and 30 min

Behavioral: Sedentary time breaks either every 30 minutesBehavioral: Sedentary time breaks every 15 minutes

Interventions

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 60 min

Also known as: Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks either every
15-60 min30-60 min60-1560-30 min

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min

Also known as: Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min
15-30 min30-15 min30-60 min60-30 min

Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 15 min

Also known as: Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks either every 15 minutes
15-30 min15-60 min30-15 min60-15

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals with type 2 diabetes for less than 10 years
  • Individuals aged 35-60 years
  • Individuals receiving metformin or diet control
  • Non-smokers
  • Overweight and obese individuals (BMI 25-35 kg/m2)
  • Individuals with an HbA1c between \>7%
  • Individuals with BP below 160/90mmHg

You may not qualify if:

  • Individuals unable or unwilling to consent
  • Individuals under the age of 35 years and over the age of 60 years at study enrolment
  • Patients on sulphonylurea or other oral hypoglycaemic drugs therapy except metformin
  • Individuals with hepatic or renal dysfunction
  • Individuals with body mass index greater than 35
  • Individuals suffering from cancer, cardiovascular diseases, cirrhosis, hepatitis and renal disease
  • Pregnant Individuals
  • Individuals who smoke
  • Individuals who are alcohol and drug abusers
  • Individuals with a blood pressure ≥160/90mmHg
  • Individuals diagnosed with anaemia (Hb\<12g/dl in women and \<13 g/dl in men)
  • Individuals taking medicines which can interfere with the glucose metabolism (e.g. anticoagulants, oral contraceptives, steroid, thiazide, β-blocker, NSAID, anti-fungal, hormonal therapy, psychotropic drugs)
  • Individual taking drugs for glycaemic control in excess of standard care highlighted by the SIGN guideline 116.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Chastin SF, Egerton T, Leask C, Stamatakis E. Meta-analysis of the relationship between breaks in sedentary behavior and cardiometabolic health. Obesity (Silver Spring). 2015 Sep;23(9):1800-10. doi: 10.1002/oby.21180.

    PMID: 26308477BACKGROUND
  • Cooper AR, Sebire S, Montgomery AA, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Dayan CM, Andrews RC. Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia. 2012 Mar;55(3):589-99. doi: 10.1007/s00125-011-2408-x. Epub 2011 Dec 14.

    PMID: 22167127BACKGROUND
  • Dempsey, P.C., Owen, N., Larsen, R., Straznicky, N., Cohen, Neale., FACSM, B.B., Kingwell, B.A., Dunstan, D.W., Baker IDI Heart and Diabetes Institute, Melbourne, Australia., Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado, USA. 2015. Interrupting Prolonged Sitting: A Potential Therapeutic Tool in the Management of Type 2 Diabetes

    BACKGROUND
  • Dunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, Shaw JE, Bertovic DA, Zimmet PZ, Salmon J, Owen N. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012 May;35(5):976-83. doi: 10.2337/dc11-1931. Epub 2012 Feb 28.

    PMID: 22374636BACKGROUND
  • Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, Owen N. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care. 2008 Apr;31(4):661-6. doi: 10.2337/dc07-2046. Epub 2008 Feb 5.

    PMID: 18252901BACKGROUND
  • Henson J, Yates T, Biddle SJ, Edwardson CL, Khunti K, Wilmot EG, Gray LJ, Gorely T, Nimmo MA, Davies MJ. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia. 2013 May;56(5):1012-20. doi: 10.1007/s00125-013-2845-9. Epub 2013 Mar 1.

    PMID: 23456209BACKGROUND
  • Latouche C, Jowett JB, Carey AL, Bertovic DA, Owen N, Dunstan DW, Kingwell BA. Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol (1985). 2013 Feb 15;114(4):453-60. doi: 10.1152/japplphysiol.00978.2012. Epub 2012 Dec 27.

    PMID: 23271697BACKGROUND
  • Peddie MC, Bone JL, Rehrer NJ, Skeaff CM, Gray AR, Perry TL. Breaking prolonged sitting reduces postprandial glycemia in healthy, normal-weight adults: a randomized crossover trial. Am J Clin Nutr. 2013 Aug;98(2):358-66. doi: 10.3945/ajcn.112.051763. Epub 2013 Jun 26.

    PMID: 23803893BACKGROUND
  • Paing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Chastin SFM. Dose-response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes. Diabet Med. 2019 Mar;36(3):376-382. doi: 10.1111/dme.13829. Epub 2018 Oct 12.

MeSH Terms

Conditions

Diabetes MellitusSedentary Behavior

Interventions

Sitting Position

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Andrew Collier,, MBchb

    Glasgow Caledonian University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sebastian Chastin, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2016

First Posted

April 14, 2016

Study Start

May 1, 2016

Primary Completion

January 1, 2017

Study Completion

April 1, 2017

Last Updated

April 14, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share